What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Venom, Biochemistry, Spider Venoms, Inhibitor cystine knot and Peptide.
His biological study spans a wide range of topics, including Zoology, Insect and Pharmacology.
His Pharmacology research incorporates themes from Receptor, In vitro, Sodium channel and Drug discovery.
His studies in Drug discovery integrate themes in fields like Spider and Computational biology.
His study focuses on the intersection of Inhibitor cystine knot and fields such as Cystine knot with connections in the field of DNA, Beta sheet and Homology.
His research in the fields of Cone snail overlaps with other disciplines such as Nomenclature.
His most cited work include:
- The Toxicogenomic Multiverse: Convergent Recruitment of Proteins Into Animal Venoms (506 citations)
- Venoms as a platform for human drugs: translating toxins into therapeutics (323 citations)
- Spider-venom peptides: structure, pharmacology, and potential for control of insect pests (233 citations)
What are the main themes of his work throughout his whole career to date?
Glenn F. King mainly investigates Venom, Biochemistry, Peptide, Stereochemistry and Spider Venoms.
His Venom study integrates concerns from other disciplines, such as Zoology, Spider, Insect and Inhibitor cystine knot.
Within one scientific family, Glenn F. King focuses on topics pertaining to Biophysics under Biochemistry, and may sometimes address concerns connected to Membrane.
His Peptide study combines topics in areas such as Amino acid, Sodium channel, Ion channel, Computational biology and Pharmacology.
His study in Computational biology is interdisciplinary in nature, drawing from both Proteomics and Drug discovery.
Spider Venoms connects with themes related to Spider toxin in his study.
He most often published in these fields:
- Venom (29.63%)
- Biochemistry (27.90%)
- Peptide (21.23%)
What were the highlights of his more recent work (between 2017-2021)?
- Venom (29.63%)
- Peptide (21.23%)
- Biochemistry (27.90%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Venom, Peptide, Biochemistry, Pharmacology and Biophysics.
Spider Venoms is the focus of his Venom research.
His Peptide research includes themes of Proteomics, Potency, Pharmacophore, Stereochemistry and Ant venom.
Glenn F. King has researched Pharmacology in several fields, including Chronic pain, Reperfusion injury, Ischemia, Acid-sensing ion channel and In vivo.
His Biophysics research is multidisciplinary, incorporating elements of Quantum dot, Membrane, Sodium channel and Binding site.
His work carried out in the field of Computational biology brings together such families of science as Drug discovery and Molecular targets.
Between 2017 and 2021, his most popular works were:
- Structural basis for the modulation of voltage-gated sodium channels by animal toxins (99 citations)
- ArachnoServer 3.0: an online resource for automated discovery, analysis and annotation of spider toxins. (52 citations)
- Selective NaV1.1 activation rescues Dravet syndrome mice from seizures and premature death (50 citations)
In his most recent research, the most cited papers focused on:
Glenn F. King mainly focuses on Venom, Computational biology, Spider Venoms, Zoology and Peptide.
His Venom research is multidisciplinary, relying on both Evolutionary biology, Prey capture, Peptide sequence, Gene duplication and Insect.
His study looks at the intersection of Computational biology and topics like Molecular targets with Biological activity.
Glenn F. King has researched Spider Venoms in several fields, including World Wide Web and Function.
His Zoology research integrates issues from Molecular evolution and Predation.
His study in Peptide is interdisciplinary in nature, drawing from both Annotation, Receptor, Pharmacophore, Structure–activity relationship and Binding site.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
